Your AI investment needs a business case that survives the finance meeting
Connect ambition to the cost, quality and adoption evidence behind it.
Discussion CornerCFO & Business Value
THE MONTHLY JOURNAL / GENELLIPSE
CFO & Business Value
Corner.
Invest with discipline. Prove the value.
Technology economics, investment decisions and measurable transformation outcomes for finance and business leaders.
Office of Business Value, GENELLIPSE
AN ONGOING PERSPECTIVEMonthly editions · Practical business guidance
Original AI-generated editorial image. The people and setting are illustrative.
LATEST EDITION / October 2026
Your AI investment needs a business case that survives the finance meeting
Connect ambition to the cost, quality and adoption evidence behind it.
Read the discussionTHE QUESTIONS BEHIND THE TECHNOLOGY
01Investment & benefits
02Technology economics
03Value realization
A business issue. A practical response. A clear owner.
THE MONTHLY ARCHIVE
Every edition. A continuing conversation.
Monthly editions from January 2026, with new perspectives added to the same archive. Earlier editions are identified as retrospective; every article retains its own permanent link.
10 matching discussions
A healthy transformation portfolio can stop a project
Funding discipline includes the ability to change direction.
The cost of poor data is hidden in ordinary work
Find the effort before buying another reporting tool.
Capacity released is not automatically cash saved
Build a practical plan for the time automation creates.
A merger synergy needs an integration plan
Convert an acquisition assumption into a controlled operating change.
Match cloud commitments to a credible demand picture
Discounts are valuable when the organization can use what it buys.
Translate technical debt into a business decision
Show where architecture constrains service, cost and change.
A software renewal is an investment decision
Recover value by examining usage, overlap and the cost of leaving.
Price the completed outcome, not the AI interaction
A low unit price can conceal a costly business process.
Before approving the investment, agree the baseline
A credible value case begins with a shared account of today.
FROM PERSPECTIVE TO PRACTICE
Bring the discussion
into your organization.
Genellipse can connect GeneData cost and operational records with GeneAnalytics reporting, supported by architecture and transformation services. We agree a baseline, accountable benefit owners and a method for verifying outcomes. Cortex AI can assist defined analytical workflows with human review. Commercial commitments and achievable savings depend on the agreed scope and evidence; illustrative calculations are not promised returns.
Talk with GenellipseOffice of Business Value, GENELLIPSE